Research graph
References from Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system
10.1002/cncr.29056 · 2014 · External reference
Treatment of stage I and II non-small cell lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
10.1378/chest.12-2359 · 2013 · External reference
Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials
10.1016/s1470-2045(09)70103-2 · 2009 · External reference
Stereotactic body radiation therapy for inoperable early stage lung cancer
10.1001/jama.2010.261 · 2010 · External reference
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy
10.1200/jco.2008.21.5681 · 2009 · External reference
Stereotactic hypofractionated radiotherapy in stage I (T1–2 N0 M0) non-small-cell lung cancer (NSCLC)
10.1080/02841860600913210 · 2006 · External reference
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
10.1016/0021-9681(87)90171-8 · 1987 · External reference
Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer
10.1097/jto.0000000000000416 · 2015 · External reference
Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer
10.1016/j.radonc.2009.06.002 · 2009 · External reference
Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis
10.1245/s10434-014-3860-x · 2014 · External reference
Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy
2010 · External reference
Inoperable early stage non-small cell lung cancer: comorbidity, patterns of care and survival
10.1016/j.lungcan.2010.07.015 · 2011 · External reference
Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer
10.1183/09031936.05.00146004 · 2005 · External reference
Predictive ability of Charlson Comorbidity Index on outcomes from lung cancer
10.1097/coc.0b013e3181fe445b · 2011 · External reference
Comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer
10.1136/thx.2003.018044 · 2004 · External reference
Purposeful selection of variables in logistic regression
10.1186/1751-0473-3-17 · 2008 · External reference
Prediction of early death in patients with early-stage NSCLC –Can we select patients without a potential benefit of SBRT as a curative treatment approach?
10.1016/j.jtho.2016.03.016 · 2016 · External reference
